STAT+: What’s the deal with Isomorphic Labs?
In this edition of STAT's AI Prognosis: What does Isomorphic Labs' high valuation say about AI's role in drug development, and the debate around AI and cost of care.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.